Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Other Non Operating Income (2017 - 2025)

Marimed (MRMD) has disclosed Other Non Operating Income for 10 consecutive years, with $19000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non Operating Income changed N/A to $19000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $86000.0, a 100.96% increase, with the full-year FY2023 number at -$10.4 million, changed N/A from a year prior.
  • Other Non Operating Income was $19000.0 for Q3 2025 at Marimed, up from $17000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.0 million in Q1 2022 to a low of -$8.9 million in Q4 2023.
  • A 5-year average of -$627764.7 and a median of -$24000.0 in 2022 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: skyrocketed 100300.0% in 2022, then tumbled 36879.17% in 2023.
  • Marimed's Other Non Operating Income stood at -$214000.0 in 2021, then surged by 88.79% to -$24000.0 in 2022, then crashed by 36879.17% to -$8.9 million in 2023, then skyrocketed by 100.56% to $50000.0 in 2024, then tumbled by 62.0% to $19000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Other Non Operating Income are $19000.0 (Q3 2025), $17000.0 (Q2 2025), and $50000.0 (Q4 2024).